NOTE: the TTN coding DNA reference sequence used has been changed to NM_001267550.1. For details see the TTN coding DNA reference sequence.
LOVD TTN homepage

General information
Gene name Titin
Gene symbol TTN
Chromosome Location 2q31
Database location the Leiden Muscular Dystrophy pages
Curator Claire Chauveau and Johan den Dunnen
PubMed references View all (unique) PubMed references in the TTN database
Date of creation January 01, 2006
Last update November 08, 2015
Version TTN151108
Add sequence variant Submit a sequence variant
First time submitters Register here
Reference sequence file coding DNA reference sequence for describing sequence variants
Genomic refseq ID NG_011618.2
Transcript refseq ID NM_001267550.1
Exon/intron information Exon/intron information table
Total number of unique DNA variants reported 611
Total number of individuals with variant(s) 3684
Total number of variants reported 4111
Subscribe to updates of this gene
NOTE NOTE: the TTN coding DNA reference sequence used has been changed to NM_001267550.1. For details see the TTN coding DNA reference sequence.

Graphical displays and utilities
Summary tables Summary of all sequence variants in the TTN database, sorted by type of variant (with graphical displays and statistics)
Reading-frame checker The Reading-frame checker generates a prediction of the effect of whole-exon changes
UCSC Genome Browser Show variants in the UCSC Genome Browser (compact view)
Ensembl Genome Browser Show variants in the Ensembl Genome Browser (compact view)
NCBI Sequence Viewer Show distribution histogram of variants in the NCBI Sequence Viewer

Sequence variant tables
Unique sequence variants Listing of all unique sequence variants in the TTN database, without patient data
Complete sequence variant listing Listing of all sequence variants in the TTN database
Variants with no known pathogenicity Listing of all TTN variants reported to have no noticeable phenotypic effect (note: excluding variants of unknown effect)

Search the database
By type of variant View all sequence variants of a certain type
Simple search Query the database by selecting the most important variables (exon number, type of variant, disease phenotype)
Advanced search Query the database by selecting a combination of variables
Based on patient origin View all variants based on your patient origin search terms
Search through hidden entries Find the number of variant entries in the database (including hidden entries) matching your search terms.

Links to other resources
HGNC 12403
Entrez Gene 7273
OMIM - Gene 188840
OMIM - Disease #1 limb-girdle muscular dystrophy, type 2J (LGMD-2J)
OMIM - Disease #2 tibial muscular dystrophy (TMD)
OMIM - Disease #3 cardiomyopathy, dilated, type 1G (CMD-1G)
OMIM - Disease #4 CMH-9
OMIM - Disease #5 hereditary myopathy with early respiratory failure (HMERF)
OMIM - Disease #6 early-onset myopathy with fatal cardiomyopathy (EOMFC)
GeneCards TTN
GeneTests TTN

Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective curator(s). Any unauthorised use, copying, storage or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2015. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising out of any inaccuracies or omissions. Individuals, organisations and companies which use this database do so on the understanding that no liability whatsoever either direct or indirect shall rest upon the curator(s) or any of their employees or agents for the effects of any product, process or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.